Windtree Therapeutics Inc (WINT)

[N_B]

Windtree Therapeutics to Host Conference Call and Webcast on Tuesday, October 25, 2016 to Provide a Business Update

WARRINGTON, Pa., Oct. 20, 2016 /PRNewswire/ -- Windtree Therapeutics, Inc. (Nasdaq: WINT), a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, will host a conference call and webcast (including a slide presentation) at 8:00 a.m. EDT on Tuesday, October 25, 2016 to provide updates on the AEROSURF® phase 2 clinical program and the lung deposition study in non-human primates.

To participate in the live call and take part in the question and answer session, dial [phone] (domestic) or [phone] (international). The live webcast, including a slide presentation, can be accessed at http://windtreetx.investorroom.com/events .

A replay of the conference call will be accessible one hour after completion through November 1, 2016 by dialing [phone] (domestic) or [phone] (international) and referencing conference ID number 10095419. An archive of the webcast can be accessed on the Company's website at http://windtreetx.investorroom.com/events


http://windtreetx.investorroom.com/2016-10-20-Windtree-Therapeutics-to-Host-Conference-Call-and-Webcast-on-Tuesday-October-25-2016-to-Provide-a-Business-Update